7 Cara Vivix Bantu Tubuh Merawat Buah Pinggang

0
40

7 Cara Vivix Bantu Tubuh Merawat Buah Pinggang

Ada 2 faktor yang kerap dikaitkan dengan penyakit buah pinggang iaitu :

1. Keradangan sistemik

2. Tekanan oksidatif

Tekanan oksidatif ialah ketidakseimbangan radikal bebas dan kapasiti antioksidan dalam tubuh.

Kita umpamakan tekanan oksidatif seperti paku yang terbiar dan berkarat. Semakin lama karat akan melemahkan paku.

Begitu juga dengan buah pinggang. Tekanan oksidatif ini membuatkan tisu buah pinggang semakin lemah dan ini dikaitkan dengan masalah buah pinggang.

 


Vivix Sebagai Nutrisi Sel Buah Pinggang

 

Resveratrol yang juga terdapat dalam Vivix, dalam banyak kajian telah menunjukkan kesan yang baik termasuk:

  • Berperanan sebagai anti radang
  • Membantu meningkatkan pengeluaran enzim antioksidan

Secara spesifiknya, Vivix dan resveratrol terbaik untuk nutrisi buah pinggang melalui 7 cara:

1. Antioksidan:

  • Mengurangkan tekanan oksidatif pada sel nepron buah pinggang.
  • Mengelakkan berlaku kerosakan yang lebih teruk pada saraf buah pinggang.

2. Meningkatkan struktur dan bentuk buah pinggang yang normal

3. Mengurangkan penggumpalan platlet pada buah pinggang

4. Mengembangkan salur darah pada buah pinggang

5. Mengurangkan proses lipid peroksida.

6. Mengurangkan kematian sel saraf buah pinggang

7. Memberikan tenaga pada sel sekaligus pesakit buah pinggang akan merasa bertenaga

 


Apakah Resveratrol

Dalam Vivix terdapat bahan yang disebut sebagai resveratrol.

Resveratrol adalah sejenis antioksida – polifenol yang didapati pada tumbuhan, buah-buahan, bijian dan kekacang.

Kulit anggur merah mengandungi konsentrasi resveratrol yang sangat tinggi.

Resveratrol ini akan bertindak umpama ‘sistem imunisasi’ yang memelihara keadaan sel dalam tubuh dari virus dan bakteria.

Kajian mengenai resveratrol telah diterbitkan di dalam lebih 2000 jurnal.

Penerbitan jurnal antaranya oleh University Harvard, National Institute of Aging, National Cancer Institute dan National Cancer Institute of Science.

Ia termasuk beberapa hasil menunjukkan reveratrol :

  • Merencatkan gen kanser
  • Keupayaan menterbalikkan kesilapan DNA
  • Keupayaan sebagai anti kanser

 


Dari Tahap 4 Buah Pinggang Kepada Normal Dengan Vivix

Tahap kerosakan buah pinggang, dirujuk pada indeks GFR.

GFR adalah Glomerular Filtration Rate. Berikut adalah jadual tahap GFR

Dalam perubatan, masalah buah pinggang hanya akan dilaporkan apa berada pada tahap 59 dan ke bawah.

Pada tahap 2 (antara 60-89), kerosakan telahpun mula berlaku.

Adalah penting untuk cegah ia dari semakin teruk dan berikan tubuh sokongan memperbaiki keadaannya.

 


Kos Dialisis vs Kos Vivix

Saya adalah ahli Persatuan Pesakit Buah Pinggang, Telok Panglima Garang.

Di sini, kos rawatan adalah RM200 untuk sekali dialisis. Setiap pesakit perlu lakukan 3 kali seminggu, 4 jam setiap sesi.

Alhamdulillah, selama lebih 10 tahun pusat dialisis ini beroperasi pesakit mendapat sponsor sebanyak RM50 setiap sesi rawatan dari pusat Dialisis Sijangkang sendiri.

Majoriti pesakit di sini, mendapat bantuan dari Pusat Zakat Selangor. Rata-rata hanya mendapat RM150 sahaja. Dan ia tidak mencukupi untuk menampung kos asas rawatan.

 

Dialisis air : Peritoneal Dialisis (PD)

Untuk pesakit yang membuat rawatan dialisis air (biasanya dibuat di rumah), ia sekitar RM2600 sebulan.

Rawatan ini memerlukan mesin sendiri (dibeli sendiri) dan dilakukan setiap beberapa jam sekali.

Salah satu risiko utama adalah jangkitan kerana tahap kebersihan bilik perlu dijaga rapi dan prosedur yang perlu dilakukan sendiri.

Untuk peritoneal dialisis, bahagian abdomen pesakit ditebuk dan dimasukkan tiub untuk proses rawatan setiap beberapa jam sekali.

Allahyarham ayah angkat saya buat Peritonela Dialisis selama beberapa bulan sebelum berlaku jangkitan.

Kemudian bertukar kepada hemodialisis dan lakukannya di pusat rawatan untuk beberapa tahun selepas itu.

Perjalanan pergi ke pusat dialisis terdekat pula adalah sekitar 30 minit sehala (Nitar – Mersing).

Kos survival seorang pesakit dialisis sememangnya besar.

 

Dialisis darah : Hemodialisis

Hemodialisis adalah percuma sekiranya dibuat di hospital, namun perlu menunggu dalam senarai nama yang panjang.

Pesakit buah pinggang memang ramai.

BACA : 6000 Pesakit Buah Pinggang Setiap Tahun

Di pusat dialisis swasta, kosnya adalah RM200-RM250 sekali dialisis. Wajib 3 kali seminggu.

Kos ubat-ubatan mungkin berbeza mengikut keadaan. Semuanya boleh mencecah RM3000 tidak termasuk kos perjalanan pergi dan balik.

Kos rawatan, untuk yang bekerja dengan kerajaan, boleh claim semula. Pekerja swasta boleh dapat tuntutan SOCSO.

Untuk anda yang bekerja sendiri, perlu sepenuhnya ditanggung sendiri.

Ini adalah salah satu jenis mesin hemodialisis yang biasanya digunakan di pusat rawatan.

Kerosakan buah pinggang tahap 1 hingga tahap 4 masih boleh diselamatkan. Jika sampai ke tahap 5 bermaksud tiada harapan sembuh.

Pesakit hanya boleh teruskan hidup dengan bergantung kepada rawatan dialisis. 3 kali seminggu 4 jam setiap sesi atau pemindahan buah pinggang sahaja.

Jadi, selamatkan buah pinggang anda sekarang sebelum ia rosak secara total.

  1. Jaga makan. Pilih corak pemakanan sihat.
  2. Lakukan aktiviti fizikal seperti bersenam.
  3. Dapatkan supplemen untuk menyokong tubuh sembuhkan dirinya secara semulajadi.

Usaha tambahan untuk selamatkan buah pinggang dengan sokongan Vivix hanya rm503 (harga runcit) dan harga ahli cuma RM403.

Biasa customer jadi ahli terus sekiranya ambil Vivix.

Bagi tempoh 6 bulan untuk ambil Vivix, kos hanya rm2418 (harga ahli) jika diambil 1 botol sebulan.

Ia lebih menjimatkan dan anda akan nampak perubahan lebih baik dan ketara.

Vivix adalah nutrisi yang kaya dengan antioksidan untuk membantu tubuh memperbaiki sel buah pinggang.

Ini dapat mengelakkan anda daripada terus dialisis seumur hidup yang akan menghabiskan masa di pusat rawatan.

Bermaksud, jika anda masih bekerja anda akan cuti 3 hari dalam seminggu untuk sesi rawatan. Pendapatan sedia ada terjejas, simpanan akan terus susut.

Dengan pengambilan Vivix :

  • Pesakit akan lebih bertenaga
  • Boleh membantu turunkan tahap buah pinggang (GFR)

Produk Shaklee adalah terbaik dari segi kualiti, jaminan keselamatan ramuan/produk dan keberkesanan. InsyaAllah

Semoga perkongsian ini bermanfaat.

Jika anda ingin mendapatkan produk Shaklee atau menyertai Shaklee, hubungi :
#masterlatifcom (0184024608 – Latif)
#jihadinbuildinghealth


Rujukan Tambahan
  1. S. Shastri and M. J. Sarnak, “Cardiovascular disease and CKD: core curriculum 2010,” American Journal of Kidney Diseases, vol. 56, no. 2, pp. 399–417, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Stenvinkel, “Inflammation as a target for improving health in chronic kidney disease,” F1000 Medicine Reports, vol. 17, no. 1, Article ID M2-88, pp. 2–88, 2010. View at Publisher · View at Google Scholar ·View at Scopus
  3. M. L. Wratten, D. Galaris, C. Tetta, and A. Sevanian, “Evolution of oxidative stress and inflammation during hemodialysis and their contribution to cardiovascular disease,” Antioxidants and Redox Signaling, vol. 4, no. 6, pp. 935–944, 2002. View at Google Scholar · View at Scopus
  4. M. Kobayashi, H. Sugiyama, D.-H. Wang et al., “Catalase deficiency renders remnant kidneys more susceptible to oxidant tissue injury and renal fibrosis in mice,” Kidney International, vol. 68, no. 3, pp. 1018–1031, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Sener, K. Paskaloglu, H. Satiroglu, I. Alican, A. Kaçmaz, and A. Sakarcan, “l-Carnitine ameliorates oxidative damage due to chronic renal failure in rats,” Journal of Cardiovascular Pharmacology, vol. 43, no. 5, pp. 698–705, 2004. View at Publisher · View at Google Scholar
  6. G. J. Soleas, E. P. Diamandis, and D. M. Goldberg, “Resveratrol: a molecule whose time has come? And gone?” Clinical Biochemistry, vol. 30, no. 2, pp. 91–113, 1997. View at Publisher · View at Google Scholar· View at Scopus
  7. G. Spanier, H. Xu, N. Xia et al., “Resveratrol reduces endothelial oxidative stress by modulating the gene expression of superoxide dismutase 1 (SOD1), glutathione peroxidase 1 (GPx1) and NADPH oxidase subunit (Nox4),” Journal of Physiology and Pharmacology, vol. 60, pp. 111–116, 2009. View at Google Scholar · View at Scopus
  8. P. Palsamy and S. Subramanian, “Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling,” Biochimica et Biophysica Acta, vol. 1812, no. 7, pp. 719–731, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Ghanim, C. L. Sia, S. Abuaysheh et al., “An antiinflammatory and reactive oxygen species suppressive effects of an extract of Polygonum cuspidatum containing resveratrol,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 9, pp. E1–E8, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Himmelfarb, P. Stenvinkel, T. A. Ikizler, and R. M. Hakim, “Perspectives in renal medicine: the elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia,” Kidney International, vol. 62, no. 5, pp. 1524–1538, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Locatelli, B. Canaud, K.-U. Eckardt, P. Stenvinkel, C. Wanner, and C. Zoccali, “Oxidative stress in end-stage renal disease: an emerging treat to patient outcome,” Nephrology Dialysis Transplantation, vol. 18, no. 7, pp. 1272–1280, 2003. View at Google Scholar · View at Scopus
  12. B. Descamps-Latscha, T. Drüeke, and V. Witko-Sarsat, “Dialysis-induced oxidative stress: biological aspects, clinical consequences, and therapy,” Seminars in Dialysis, vol. 14, no. 3, pp. 193–199, 2001. View at Google Scholar · View at Scopus
  13. C. L. Meuwese, P. Stenvinkel, F. W. Dekker, and J. J. Carrero, “Monitoring of inflammation in patients on dialysis: forewarned is forearmed,” Nature Reviews Nephrology, vol. 7, no. 3, pp. 166–176, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. J. J. Carrero and P. Stenvinkel, “Inflammation in end-stage renal disease—what have we learned in 10 years?” Seminars in Dialysis, vol. 23, no. 5, pp. 498–509, 2010. View at Publisher · View at Google Scholar· View at Scopus
  15. N. D. Vaziri, “Roles of oxidative stress and antioxidant therapy in chronic kidney disease and hypertension,” Current Opinion in Nephrology and Hypertension, vol. 13, no. 1, pp. 93–99, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Bonanni, I. Mannucci, D. Verzola et al., “Protein-energy wasting and mortality in chronic kidney disease,” International Journal of Environmental Research and Public Health, vol. 8, no. 5, pp. 1631–1654, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Kim, Y.-N. Cha, and Y.-J. Surh, “A protective role of nuclear factor-erythroid 2-related factor-2 (Nrf2) in inflammatory disorders,” Mutation Research, vol. 690, no. 1-2, pp. 12–23, 2010. View at Publisher ·View at Google Scholar · View at Scopus
  18. L. Hajra, A. I. Evans, M. Chen, S. J. Hyduk, T. Collins, and M. I. Cybulsky, “The NF-κB signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 16, pp. 9052–9057, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Csiszar, M. Wang, E. G. Lakatta, and Z. Ungvari, “Inflammation and endothelial dysfunction during aging: Role of NF-κB,” Journal of Applied Physiology, vol. 105, no. 4, pp. 1333–1341, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. J. S. Tilstra, A. R. Robinson, J. Wang et al. et al., “NF-κB inhibition delays DNA damade-induced senescence and aging in mice,” The Journal of Clinical Investigation, vol. 122, no. 7, pp. 2601–2612, 2012.View at Publisher · View at Google Scholar
  21. I. L. Noronha, C. K. Fujihara, and R. Zatz, “The inflammatory component in progressive renal disease—are interventions possible?” Nephrology Dialysis Transplantation, vol. 17, no. 3, pp. 363–368, 2002. View at Google Scholar · View at Scopus
  22. A. Kuhad and K. Chopra, “Attenuation of diabetic nephropathy by tocotrienol: involvement of NFκB signaling pathway,” Life Sciences, vol. 84, no. 9-10, pp. 296–301, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. I. Manabe, “Chronic inflammation links cardiovascular, metabolic and renal diseases,” Circulation Journal, vol. 75, no. 12, pp. 2739–2748, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Pedruzzi, M. B. Stockler-Pinto, M. Leite Jr., and D. Mafra, “Nrf2 keap-1 system versus NF-κB: the good and the evil in chronic kidney disease?” Biochimie, vol. 94, no. 12, pp. 2461–2466, 2012. View at Google Scholar
  25. K.-A. Jung and M.-K. Kwak, “The Nrf2 system as a potential target for the development of indirect antioxidants,” Molecules, vol. 15, no. 10, pp. 7266–7291, 2010. View at Publisher · View at Google Scholar· View at Scopus
  26. S. Singh, S. Vrishni, B. K. Singh, I. Rahman, and P. Kakkar, “Nrf2-ARE stress response mechanism: a control point in oxidative stress-mediated dysfunctions and chronic inflammatory diseases,” Free Radical Research, vol. 44, no. 11, pp. 1267–1288, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Wang, L. Mao, L. Qiao, and X. Wang, “Disruption of Nrf2 enhances the upregulation of nuclear factor-κB activity, tumor necrosis factor-α, and matrix metalloproteinase-9 after spinal cord injury in mice,” Mediators of Inflammation, vol. 2010, Article ID 238321, 10 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Domitrovic, H. Jakovac, V. Vasiljev Marchesi et al., “Differential hepatoprotective mechanisms of rutin and quercetin in CCI4-intoxicated BALB/cN mice,” Acta Pharmacologica Sinica, vol. 33, pp. 1260–1270, 2012. View at Google Scholar
  29. R. J. Thoppil, D. Bhatia, K. F. Barnes et al., “Black currant anthocyanins abrogate oxidative stress through Nrf2-mediated antioxidant mechanisms in a rat model of hepatocellular carcinoma,” Current Cancer Drug Targets, vol. 12, no. 9, pp. 1244–1257, 2012. View at Google Scholar
  30. Y. Wu and F. Liu, “Targeting mTOR: evaluating the therapeutic potential of resveratrol for cancer treatment,” Anti-Cancer Agents in Medicinal Chemistry, vol. 13, no. 7, pp. 1032–1038, 2012. View at Google Scholar
  31. M. J. Takaota, “The phenolic substances of white hellebore (Veratrum grandiflorum Loes. Fil.),” Journal of the Faculty of Science, Hokkaido Imperial University, vol. 3, pp. 1–16, 1940. View at Google Scholar
  32. E. H. Siemann and L. L. Creasy, “Concentration of the phytoalexin resveratrol in wine,” American Journal of Enology and Viticulture, vol. 43, pp. 49–52, 1992. View at Google Scholar
  33. B.-L. Liu, X. Zhang, W. Zhang, and H.-N. Zhen, “New enlightenment of French paradox: resveratrol’s potential for cancer chemoprevention and anti-cancer therapy,” Cancer Biology and Therapy, vol. 6, no. 12, pp. 1833–1836, 2007. View at Google Scholar · View at Scopus
  34. S. Timmers, J. Auwerx, and P. Schrauwen, “The journey of resveratrol from yeast to human,” Aging, vol. 4, no. 3, pp. 146–158, 2012. View at Google Scholar
  35. B. Catalgol, S. Batirel, Y. Taga, and N. K. Ozer, “Resveratrol: french paradox revisited,” Frontiers in Pharmacology, vol. 3, pp. 1–18, 2012. View at Google Scholar
  36. H. Li and U. Fostermann, “Resveratrol: a multifunctional compound improving endothelial function,” Cardiovascular Drugs and Therapy, vol. 23, pp. 425–429, 2009. View at Google Scholar
  37. S. Timmers, E. Konings, L. Bilet et al., “Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans,” Cell Metabolism, vol. 14, no. 5, pp. 612–622, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. P. Brasnyó, G. A. Molnár, M. Mohás et al., “Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients,” British Journal of Nutrition, vol. 106, no. 3, pp. 383–389, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. X. Zhu, Q. Liu, M. Wang et al., “Activation of Sirt1 by resveratrol inhibits TNF-α induced inflammation in fibroblasts,” PloS ONE, vol. 6, no. 11, p. e27081, 2011. View at Google Scholar · View at Scopus
  40. H. Ghanim, C. L. Sia, K. Korzeniewski et al., “A resveratrol and polyphenol preparation suppresses oxidative and inflammatory stress response to a high-fat, high-carbohydrate meal,” Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 5, pp. 1409–1414, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. H. Yang, J. A. Baur, A. Chen, C. Miller, and D. A. Sinclair, “Design and synthesis of compounds that extend yeast replicative lifespan,” Aging Cell, vol. 6, no. 1, pp. 35–43, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. S. M. Wyke, S. T. Russell, and M. J. Tisdale, “Induction of proteasome expression in skeletal muscle is attenuated by inhibitors of NF-κB activation,” British Journal of Cancer, vol. 91, no. 9, pp. 1742–1750, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. K. T. Howitz, K. J. Bitterman, H. Y. Cohen et al., “Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan,” Nature, vol. 425, no. 6954, pp. 191–196, 2003. View at Publisher ·View at Google Scholar · View at Scopus
  44. C.-M. Hao and V. H. Haase, “Sirtuins and their relevance to the kidney,” Journal of the American Society of Nephrology, vol. 21, no. 10, pp. 1620–1627, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. E. Michishita, J. Y. Park, J. M. Burneskis, J. C. Barrett, and I. Horikawa, “Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins,” Molecular Biology of the Cell, vol. 16, no. 10, pp. 4623–4635, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. H. Y. Cohen, C. Miller, K. J. Bitterman et al., “Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase,” Science, vol. 305, no. 5682, pp. 390–392, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. J. T. Rodgers, C. Lerin, W. Haas, S. P. Gygi, B. M. Spiegelman, and P. Puigserver, “Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1,” Nature, vol. 434, no. 7029, pp. 113–118, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. Y. Xiao, S. Karnati, G. Qian et al. et al., “Cre-mediated stress affects sirtuin expression levels, peroxisome biogenesis and metabolism, antioxidant and proinflamatory signaling pathways,” PLoS ONE, vol. 7, no. 7, Article ID e41097, 2012. View at Publisher · View at Google Scholar
  49. K. H. Chen, M. L. Cheng, Y. H. Jing, D. T. Y. Chiu, M. S. Shiao, and J. K. Chen, “Resveratrol ameliorates metabolic disorders and muscle wasting in streptozotocin-induced diabetic rats,” American Journal of Physiology, vol. 301, pp. E853–E863, 2011. View at Google Scholar
  50. M. Liu and F. Liu, “Resveratrol inhibits mTOR signaling by targeting DEPTOR,” Communicative and Integrative Biology, vol. 4, no. 4, pp. 382–384, 2011. View at Google Scholar · View at Scopus
  51. M. Liu, S. A. Wilk, A. Wang et al., “Resveratrol inhibits mTOR signaling by promoting the interaction between mTOR and DEPTOR,” The Journal of Biological Chemistry, vol. 285, no. 47, pp. 36387–36394, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. Q. Yang and K.-L. Guan, “Expanding mTOR signaling,” Cell Research, vol. 17, no. 8, pp. 666–681, 2007.View at Publisher · View at Google Scholar · View at Scopus
  53. S. Wullschleger, R. Loewith, and M. N. Hall, “TOR signaling in growth and metabolism,” Cell, vol. 124, no. 3, pp. 471–484, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. M. Laplante and D. M. Sabatini, “MTOR signaling in growth control and disease,” Cell, vol. 149, no. 2, pp. 274–293, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. J. Liang, S. Tian, J. Han, and P. Xiong, “Resveratrol as a therapeutic agent for renal fibrosis induced by unilateral ureteral obstruction,” Renal Failure. In press.
  56. P. Castilla, A. Dávalos, J. L. Teruel et al., “Comparative effects of dietary supplementation with red grape juice and vitamin E on production of superoxide by circulating neutrophil NADPH oxidase in hemodialysis patients,” American Journal of Clinical Nutrition, vol. 87, no. 4, pp. 1053–1061, 2008. View at Google Scholar · View at Scopus
  57. P. Castilla, R. Echarri, A. Dávalos et al., “Concentrated red grape juice exerts antioxidant, hypolipidemic, and antiinflammatory effects in both hemodialysis patients and healthy subjects,” American Journal of Clinical Nutrition, vol. 84, no. 1, pp. 252–262, 2006. View at Google Scholar · View at Scopus

SOURCEJournal
MASTER LATIF
Pemasar online semenjak 2007. Pakar buat blog/website, produk digital dan pakar edit video (teaser, corporate). Aktif memberi khidmat konsultansi berkaitan kesihatan dan nutrisi semenjak 2013. Terlibat membantu lebih 3000 orang peserta untuk kurus dari rumah (online coaching) semenjak 2015. Sumbangan kepada masyarakat : 1. Sponsor coaching untuk buat blog/website bernilai RM500 (terhad untuk 2000 orang sahaja). 2. Sponsor coaching kurus dari rumah bernilai RM250 (untuk 30orang setiap bulan). Kedua-dua program masih dijalankan. Sila contact jika berminat.

Tinggalkan Jawapan